Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
Lukas Wettstein, Frank Kirchhoff, Jan Münch
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1351-1351
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Ann‐Charlotte Granholm
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3190-3190
Open Access | Times Cited: 24
Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
Simone Brogi, Roberta Ibba, Sara Rossi, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2561-2561
Open Access | Times Cited: 30
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
Pietro Gentile
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9116-9116
Open Access | Times Cited: 27
Drugs for COVID-19: An Update
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8562-8562
Open Access | Times Cited: 23
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib
Vanio Mitev
Pharmacia (2023) Vol. 70, Iss. 4, pp. 1177-1193
Open Access | Times Cited: 13
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells
Miriam Ruth Heindl, Anna-Lena Rupp, Marie Schwerdtner, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 5
TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
Gilmara Barros de Lima, Everton Nencioni, Fábio Thimoteo, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 75-75
Open Access
Dissecting the Binding Affinity of Anti-SARS-CoV-2 Compounds to Human Transmembrane Protease, Serine 2: A Computational Study
Yongwei Shi, Jianxin Shen, Tao Yan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 587-587
Open Access
Characteristics of the COVID-19 epidemic process in the Volga Federal District in 2020–2023
I. N. Tuzova, S. A. Sarskov, Elena Kuzovatova, et al.
HIV Infection and Immunosuppressive Disorders (2025) Vol. 16, Iss. 4, pp. 117-127
Open Access
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically Active
Emile Verhulst, Michelle De bruyn, Pascale Berckmans, et al.
Journal of Extracellular Vesicles (2025) Vol. 14, Iss. 3
Open Access
Interplay between endogenous hormones and immune systems in human metapneumovirus pathogenesis and management
Viviana A. Ruiz‐Pozo, Santiago Cadena-Ullauri, Rafael Tamayo‐Trujillo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex
Ildar Gabaev, Alexandra Rowland, Emilija Jovanovic, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Aprotinin—Drug against Respiratory Diseases
Alexandre V. Ivachtchenko, Andrey A. Ivashchenko, Dmitrii O. Shkil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11173-11173
Open Access | Times Cited: 11
Tmprss2 maintains epithelial barrier integrity and transepithelial sodium transport
Olivia J. Rickman, Emma Guignard, Thomas Chabanon, et al.
Life Science Alliance (2024) Vol. 7, Iss. 3, pp. e202302304-e202302304
Open Access | Times Cited: 4
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2
Ali Akbar Karimian, Mohaddeseh Behjati, Mohammad Karimian
Archives of Virology (2022) Vol. 167, Iss. 10, pp. 1931-1946
Open Access | Times Cited: 16
Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19
Sergio Vázquez-Rodríguez, Diego Ramírez-Contreras, Lisset Noriega, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10
ACE2-independent sarbecovirus cell entry is supported by TMPRSS2-related enzymes and reduces sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
Lukas Wettstein, Philip Maximilian Knaff, Christian Kersten, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 15
Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 510-510
Open Access | Times Cited: 7
In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases
Ahmed H.E. Hassan, Selwan M. El‐Sayed, Mizuki Yamamoto, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1171-1171
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top